Attached files

file filename
8-K/A - 8-K/A - AMPHENOL CORP /DE/a11-4449_18ka.htm

Exhibit 99.1

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(dollars in thousands, except per share data)

 

 

 

Three Months Ended

 

Twelve Months Ended

 

 

 

December 31,

 

December 31,

 

 

 

2010

 

2009

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

Net Sales

 

$

949,886

 

$

758,296

 

$

3,554,101

 

$

2,820,065

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

639,866

 

516,664

 

2,395,873

 

1,933,511

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

310,020

 

241,632

 

1,158,228

 

886,554

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expense

 

119,466

 

103,172

 

457,871

 

397,641

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

190,554

 

138,460

 

700,357

 

488,913

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(10,192

)

(9,496

)

(40,199

)

(36,586

)

Early extinguishment of interest rate swaps

 

 

(4,575

)

 

(4,575

)

Early extinguishment of revolving credit facility

 

 

 

(542

)

 

Other income (expenses), net

 

1,598

 

(283

)

4,072

 

(1,225

)

 

 

 

 

 

 

 

 

 

 

Income before income taxes

 

181,960

 

124,106

 

663,688

 

446,527

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

(49,493

)

(34,129

)

(161,275

)

(119,311

)

 

 

 

 

 

 

 

 

 

 

Net income

 

132,467

 

89,977

 

502,413

 

327,216

 

Less: Net income attributable to noncontrolling interests

 

(1,354

)

(2,338

)

(6,008

)

(9,382

)

 

 

 

 

 

 

 

 

 

 

Net income attributable to Amphenol Corporation

 

$

131,113

 

$

87,639

 

$

496,405

 

$

317,834

 

 

 

 

 

 

 

 

 

 

 

Net income per common share - Basic

 

$

0.75

 

$

0.51

 

$

2.86

 

$

1.85

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - Basic

 

174,914,726

 

172,487,683

 

173,785,650

 

171,607,643

 

 

 

 

 

 

 

 

 

 

 

Net income per common share - Diluted

 

$

0.74

 

$

0.50

 

$

2.82

 

$

1.83

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - Diluted

 

177,597,642

 

175,068,731

 

176,325,993

 

173,941,752

 

 

 

 

 

 

 

 

 

 

 

Dividends declared per common share

 

$

0.015

 

$

0.015

 

$

0.060

 

$

0.060

 

 



 

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollars in thousands)

 

 

 

December 31,

 

December 31,

 

 

 

2010

 

2009

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

Cash and cash equivalents

 

$

525,888

 

$

384,613

 

Short-term investments

 

98,341

 

37,770

 

Total cash, cash equivalents and short-term investments

 

624,229

 

422,383

 

Accounts receivable, less allowance for doubtful accounts of $14,946 and $18,785, respectively

 

718,545

(1)

449,591

 

Inventories

 

549,169

 

461,750

 

Other current assets

 

100,187

 

86,671

 

 

 

 

 

 

 

Total current assets

 

1,992,130

 

1,420,395

 

 

 

 

 

 

 

Land and depreciable assets, less accumulated depreciation of $611,008 and $575,187, respectively

 

366,996

 

332,875

 

Goodwill

 

1,533,299

 

1,368,672

 

Other long-term assets

 

123,432

 

97,242

 

 

 

 

 

 

 

 

 

$

4,015,857

 

$

3,219,184

 

 

 

 

 

 

 

LIABILITIES & SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

Accounts payable

 

$

384,963

 

$

292,122

 

Accrued salaries, wages and employee benefits

 

75,183

 

64,143

 

Accrued income taxes

 

65,311

 

57,272

 

Accrued acquisition-related obligations

 

39,615

 

7,244

 

Other accrued expenses

 

89,566

 

81,979

 

Short-term debt

 

352

 

399

 

 

 

 

 

 

 

Total current liabilities

 

654,990

 

503,159

 

 

 

 

 

 

 

Long-term debt

 

799,640

(1)

753,050

 

Accrued pension and post employment benefit obligations

 

176,636

 

172,235

 

Other long-term liabilities

 

41,876

 

27,922

 

 

 

 

 

 

 

Shareholders’ Equity:

 

 

 

 

 

Common stock

 

176

 

174

 

Additional paid-in capital

 

144,855

 

71,368

 

Accumulated earnings

 

2,260,581

 

1,774,625

 

Accumulated other comprehensive loss

 

(84,757

)

(100,090

)

 

 

 

 

 

 

Total shareholders’ equity attributable to Amphenol Corporation

 

2,320,855

 

1,746,077

 

 

 

 

 

 

 

Noncontrolling interests

 

21,860

 

16,741

 

 

 

 

 

 

 

Total equity

 

2,342,715

 

1,762,818

 

 

 

 

 

 

 

 

 

$

4,015,857

 

$

3,219,184

 

 


NOTE 1

The Company has a $100 million receivables securitization program that expires in May 2013. In accordance with previous accounting guidance, this facility was accounted for off balance sheet as a sale of receivables. Effective January 1, 2010, the Company adopted the amendments to the Transfers and Servicing and Consolidation Topics of the Accounting Standards Codification. The adoption of these amendments has resulted in the Company reporting transactions under this facility as long-term debt and the related receivables remain on the balance sheet. At December 31, 2010, borrowings under the securitization facility were $92 million. At December 31, 2009, $82 million in receivables were sold under the Facility and excluded from the Condensed Consolidated Balance Sheets.

 



 

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(dollars in thousands)

 

 

 

Twelve months ended

 

 

 

December 31,

 

 

 

2010

 

2009

 

 

 

 

 

 

 

Cash flow from operating activities:

 

 

 

 

 

Net income

 

$

502,413

 

$

327,216

 

Adjustments for cash flow from operating activities:

 

 

 

 

 

Depreciation and amortization

 

102,846

 

98,524

 

Net change in receivables sold under Receivables Securitization Facility

 

(82,000

)(1)

(3,000

)

Stock-based compensation expense

 

25,385

 

20,240

 

Excess tax benefits from stock-based payment arrangements

 

(14,692

)

(16,085

)

Net change in components of working capital

 

(120,072

)

144,654

 

Net change in other long-term assets and liabilities

 

11,013

 

10,748

 

 

 

 

 

 

 

Cash flow provided by operating activities

 

424,893

 

582,297

 

 

 

 

 

 

 

Cash flow from investing activities:

 

 

 

 

 

Capital additions, net

 

(107,607

)

(59,834

)

Purchase of short term investments

 

(60,216

)

(33,342

)

Investments in Acquisitions

 

(180,402

)

(280,014

)

 

 

 

 

 

 

Cash flow used in investing activities

 

(348,225

)

(373,190

)

 

 

 

 

 

 

Cash flow from financing activities:

 

 

 

 

 

Long-term borrowings under credit facilities

 

793,406

(1)

609,648

 

Repayments of long-term debt

 

(748,017

)

(1,241,582

)

Borrowings under senior notes

 

 

598,878

 

Settlement of interest rate swap agreements

 

 

(4,575

)

Payments of fees and expenses related to debt financing

 

(6,975

)

(4,650

)

Proceeds from exercise of stock options

 

46,616

 

25,481

 

Excess tax benefits from stock-based payment arrangements

 

14,692

 

16,085

 

Payments to noncontrolling interests

 

(24,588

)

(23,328

)

Dividend payments

 

(10,413

)

(10,279

)

 

 

 

 

 

 

Cash flow provided (used) in financing activities

 

64,721

 

(34,322

)

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

(114

)

(5,159

)

 

 

 

 

 

 

Net change in cash and cash equivalents

 

141,275

 

169,626

 

 

 

 

 

 

 

Cash and cash equivalents balance, beginning of period

 

384,613

 

214,987

 

 

 

 

 

 

 

Cash and cash equivalents balance, end of period

 

$

525,888

 

$

384,613

 

 


NOTE 1

The Company has a $100 million receivables securitization program. In accordance with previous accounting guidance, this facility was accounted for off balance sheet as a sale of receivables. Effective January 1, 2010, the Company adopted the amendments to the Transfers and Servicing and Consolidation Topics of the Accounting Standards Codification. As a result of the adoption transfers of receivables occurring on or after January 1, 2010 are reflected as debt issued in the Company’s Condensed Consolidated Statements of Cash Flow. Excluding the impact of adoption, long-term borrowings under credit facilities would be $711,406 resulting in cash flows used in financing activities of ($17,279) and cash flows provided by operating activities of $506,893.

 


 


 

AMPHENOL CORPORATION

SEGMENT INFORMATION

(dollars in thousands)

 

 

 

Three months ended

 

Twelve months ended

 

 

 

December 31,

 

December 31,

 

 

 

2010

 

2009

 

2010

 

2009

 

 

 

 

 

 

 

 

 

 

 

Trade Sales:

 

 

 

 

 

 

 

 

 

Interconnect Products

 

$

891,035

 

$

695,127

 

$

3,293,119

 

$

2,566,578

 

Cable Products

 

58,851

 

63,169

 

260,982

 

253,487

 

Consolidated

 

$

949,886

 

$

758,296

 

$

3,554,101

 

$

2,820,065

 

 

 

 

 

 

 

 

 

 

 

Operating income:

 

 

 

 

 

 

 

 

 

Interconnect Products

 

$

199,357

 

$

142,866

 

$

725,946

 

$

505,772

 

Cable Products

 

7,232

 

9,798

 

35,472

 

38,751

 

Stock-based compensation expense

 

(6,805

)

(4,981

)

(25,385

)

(20,241

)

Other operating expenses

 

(9,230

)

(9,223

)

(35,676

)

(35,369

)

Consolidated

 

$

190,554

 

$

138,460

 

$

700,357

 

$

488,913

 

 

 

 

 

 

 

 

 

 

 

ROS%:

 

 

 

 

 

 

 

 

 

Interconnect Products

 

22.4

%

20.6

%

22.0

%

19.7

%

Cable Products

 

12.3

%

15.5

%

13.6

%

15.3

%

Stock-based compensation expense

 

-0.7

%

-0.7

%

-0.7

%

-0.7

%

Other operating expenses

 

-1.0

%

-1.2

%

-1.0

%

-1.3

%

 

 

 

 

 

 

 

 

 

 

Consolidated

 

20.1

%

18.3

%

19.7

%

17.3

%